Biochemically defined functional and selective activity and methods for selecting selective inhibitors of holophosphatases targeting their regulatory subunits
GB201708456D0
Senolytic compounds
GB201708458D0
Prodrugs
WO2017198857A1
Retroviral capsid crystal structure and use thereof
GB201706945D0
Self-inactivating viral vector
CN109790138A
By the method for ligand modified and ligand coating iron hydroxide production maltol Fe composition
GB201701944D0
Antimicrobial compositions and their uses
GB201701827D0
Compositions comprising nanosilica particles and their use in methods of activating T lymphocytes for therapy
GB201613173D0
Electron microscopy
GB201613135D0
Genome editing
CA2982040A1
Inhibitors and their uses
WO2016092299A1
Methods and kits for predicting the response to therapy of cancer
GB201517893D0
Methods for producing carboxylate ligand modified ferric iron hydroxide colloids
GB201514649D0
2-Sulfonylpyrimidines
GB201513060D0
Methods and devices
AU2015203028A1
Blood transcriptional signature of active versus latent mycobacterium tuberculosis infection
GB201507002D0
Copper Oxo-hydroxide nanoparticles and their uses as biocidal agents
